TickerFactsScreenerDevelopers

Eloxx Pharmaceuticals, Inc. (ELOX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$4.74M2011: -$5.39M2012: -$4.39M2013: -$3.90M2014: -$4.87M2015: -$5.74M2016: -$8.84M2017: -$15.94M2018: -$31.37M2019: -$39.39M2020: -$28.17M2021: -$35.00M2022: -$31.84M2023: -$14.34M2024: -$4.71M2025: -$6.33M-$6.33M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.33M-34.2%
2024-$4.71M+67.1%
2023-$14.34M+55.0%
2022-$31.84M+9.0%
2021-$35.00M-24.3%
2020-$28.17M+28.5%
2019-$39.39M-25.6%
2018-$31.37M-96.8%
2017-$15.94M-80.2%
2016-$8.84M-54.2%
2015-$5.74M-17.8%
2014-$4.87M-24.7%
2013-$3.90M+11.0%
2012-$4.39M+18.6%
2011-$5.39M-13.7%
2010-$4.74M—